Microscope using UV instead of visible light emerging as diagnostic tool

06-Dec-2017 - MUSE image of sebaceous glandA microscope using ultraviolet light to illuminate samples enables pathologists to assess high-resolution images of biopsies and other fresh tissue samples for disease within minutes, without requiring the time-consuming preparation of conventional slides or ...

Detecting blood clot risk using biomarkers

17-Mar-2017 - Cancer is one of the hardest medical conditions to overcome, and for those who do so, the battle often does not stop at remission. Many cancers predispose patients to develop blood clots, particularly patients who are diagnosed at a late stage, which often complicates their treatment and reduces ...

New key players found in fighting fungi

Important element of immune defense against fungal infections discovered

20-Dec-2016 - Fungal infections are a serious health risk. They can be harmful especially to patients whose immune system is compromised through illness or chemotherapy. A team working at the Technical University of Munich (TUM) has discovered an important mechanism in the body's defenses against fungi. The ...

Frost & Sullivan determines a real and urgent need for novel cancer diagnostics tests

Nucleic acid based tests address the need for tests that aid in the early detection and prevention of cancer

06-Feb-2013 - The range of potential therapeutic approaches available to treat cancer is expected to expand rapidly during the next decade. Current diagnostic technologies focus on detection and diagnosis of cancer using mainly blood, faeces, urine tests or genetic tests. Testing methods are now gradually ...

Thermo Fisher Scientific and Intrinsic Bioprobes Announce Alliance in Mass Spectrometric Immunoassay (MSIA) Workflow Development

21-Jul-2010 - Thermo Fisher Scientific Inc. and Intrinsic Bioprobes (IBI) Inc. announced an alliance to co-develop and market a mass spectrometry solution that will enable researchers to perform quantitative, high-throughput, high-resolution protein biomarker assays. The solution couples the specificity of ...

Pharmacelsus’ GLP implementation exemplary for European CROs

10-Jun-2009 - Pharmacelsus obtained GLP-certification covering the complete portfolio in November 2008. The company is not only able to perform accompanying analytical services for clinical studies in addition to its preclinical services, but also decided to share its knowledge on the GLP implementation ...

Western European in vitro diagnostics market sustained by new technologies

Market earns $12.65 billion in 2014

02-Jul-2008 - Despite issues such as rising R&D costs, poor reimbursement and a decline in prices, the emergence of new technologies is boosting the Western European in vitro diagnostics (IVD) markets. While the introduction of automation and integrated platforms has spurred mature segments such as clinical ...

Lab21 acquires NPTech Ltd and appoints corporate advisors for European M&A activity

27-Mar-2008 - Lab21 has acquired NPTech Ltd, an independent clinical laboratory company providing diagnostic testing services for the NHS and private healthcare providers in the UK and parts of Europe. The acquisition of NPTech, in an undisclosed financial transaction, significantly broadens Lab21's range of ...

DPC and Thermo Electron Sign Distribution Agreement

10-Aug-2004 - Diagnostic Products Corporation (NYSE - DP) and Thermo Electron Corporation (NYSE - TMO) announce a distribution agreement for the Thermo Konelab clinical chemistry systems and the TCAutomation laboratory automation products. The agreement provides DPC with distribution rights to sell the Konelab ...